, Tracking Stock Market Picks
Enter Symbol:

down 50.48 %

THRESHOLD PHARMACEUT (THLD) rated Outperform by William Blair

Posted on: Tuesday,  Jul 10, 2012  11:25 AM ET by William Blair

William Blair rated Outperform THRESHOLD PHARMACEUT (NASDAQ: THLD) on 07/10/2012, when the stock price was $8.30. Since
then, THRESHOLD PHARMACEUT has lost 50.48% as of 12/07/2015's recent price of $4.11.
If you would have followed this William Blair's recommendation on THLD, you would have lost 50.48% of your investment in 1245 days.

Threshold is focused on the discovery, development, and commercialization of small molecule therapeutics based on `Metabolic Targeting.` This approach targets abnormal glucose metabolism - a fundamental property of most solid tumors and other diseases. The company's initial focus is the treatment of cancer and benign prostatic hyperplasia, a disease characterized by overgrowth of the prostate.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/10/2012 11:25 AM Buy
as of 12/31/2012
1 Week down  -4.10 %
1 Month down  -4.75 %
3 Months down  -41.85 %
1 YTD down  -49.27 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy